NCT00477165View on ClinicalTrials.gov

Citalopram in Irritable Bowel Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Irritable Bowel Syndrome
Interventions
DRUG

Citalopram

20mg/day for 4 weeks, then 40 mg/day for 4 weeks

DRUG

Placebo

Identical to citalopram 20mg capsules; 1 capsule/day for 4 weeks, then 2 capsules/day for 4 weeks

Trial Locations (1)

94143

UCSF, San Francisco

All Listed Sponsors
lead

Stanford University

OTHER

NCT00477165 - Citalopram in Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter